An Interim Analysis Of A Phase Ii Study Of The Combination Of Tace And Sorafenib In Patients With Unresectable Hepatocellular Carcinoma In National Cancer Center Korea (Cotsun Korea, Nct00919009).
JOURNAL OF CLINICAL ONCOLOGY（2011）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要